Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

1.

Hypotheses, rationale, design, and methods for evaluation of ischemic preconditioning assessed by sequential exercise tests in diabetic and non-diabetic patients with stable coronary artery disease--a prospective study.

Rezende PC, Garcia RM, Uchida AH, Costa LM, Scudeler TL, Melo RM, Oikawa FT, Garzillo CL, Lima EG, Segre CA, Favarato D, Girardi P, Takiuti M, Strunz CC, Hueb W, Ramires JA, Filho RK.

BMC Cardiovasc Disord. 2013 Dec 13;13:117. doi: 10.1186/1471-2261-13-117.

PMID:
24330253
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Impact of diabetes on 10-year outcomes of patients with multivessel coronary artery disease in the Medicine, Angioplasty, or Surgery Study II (MASS II) trial.

Lima EG, Hueb W, Garcia RM, Pereira AC, Soares PR, Favarato D, Garzillo CL, D'Oliveira Vieira R, Rezende PC, Takiuti M, Girardi P, Hueb AC, Ramires JA, Kalil Filho R.

Am Heart J. 2013 Aug;166(2):250-7. doi: 10.1016/j.ahj.2013.04.017. Epub 2013 Jun 15.

PMID:
23895807
[PubMed - indexed for MEDLINE]
3.

Long-term analysis of left ventricular ejection fraction in patients with stable multivessel coronary disease undergoing medicine, angioplasty or surgery: 10-year follow-up of the MASS II trial.

Garzillo CL, Hueb W, Gersh BJ, Lima EG, Rezende PC, Hueb AC, Vieira RD, Favarato D, Pereira AC, Soares PR, Serrano CV Jr, Ramires JA, Kalil Filho R.

Eur Heart J. 2013 Nov;34(43):3370-7. doi: 10.1093/eurheartj/eht201. Epub 2013 Jul 4.

PMID:
23828828
[PubMed - indexed for MEDLINE]
Free Article
4.

Effect of hypoglycemic agents on ischemic preconditioning in patients with type 2 diabetes and symptomatic coronary artery disease.

Rahmi RM, Uchida AH, Rezende PC, Lima EG, Garzillo CL, Favarato D, Strunz CM, Takiuti M, Girardi P, Hueb W, Kalil Filho R, Ramires JA.

Diabetes Care. 2013 Jun;36(6):1654-9. doi: 10.2337/dc12-1495. Epub 2012 Dec 18.

PMID:
23250803
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Strategies for multivessel revascularization in patients with diabetes.

Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, Yang M, Cohen DJ, Rosenberg Y, Solomon SD, Desai AS, Gersh BJ, Magnuson EA, Lansky A, Boineau R, Weinberger J, Ramanathan K, Sousa JE, Rankin J, Bhargava B, Buse J, Hueb W, Smith CR, Muratov V, Bansilal S, King S 3rd, Bertrand M, Fuster V; FREEDOM Trial Investigators.

N Engl J Med. 2012 Dec 20;367(25):2375-84. doi: 10.1056/NEJMoa1211585. Epub 2012 Nov 4.

PMID:
23121323
[PubMed - indexed for MEDLINE]
Free Article
6.

Effect of complete revascularization on 10-year survival of patients with stable multivessel coronary artery disease: MASS II trial.

Vieira RD, Hueb W, Gersh BJ, Lima EG, Pereira AC, Rezende PC, Garzillo CL, Hueb AC, Favarato D, Soares PR, Ramires JA, Kalil Filho R.

Circulation. 2012 Sep 11;126(11 Suppl 1):S158-63.

PMID:
22965977
[PubMed - indexed for MEDLINE]
Free Article
7.

Cost-effectiveness analysis for surgical, angioplasty, or medical therapeutics for coronary artery disease: 5-year follow-up of medicine, angioplasty, or surgery study (MASS) II trial.

Vieira RD, Hueb W, Hlatky M, Favarato D, Rezende PC, Garzillo CL, Lima EG, Soares PR, Hueb AC, Pereira AC, Ramires JA, Kalil Filho R.

Circulation. 2012 Sep 11;126(11 Suppl 1):S145-50.

PMID:
22965975
[PubMed - indexed for MEDLINE]
Free Article
8.

Ten-year outcomes of patients randomized to surgery, angioplasty, or medical treatment for stable multivessel coronary disease: effect of age in the Medicine, Angioplasty, or Surgery Study II trial.

Rezende PC, Hueb W, Garzillo CL, Lima EG, Hueb AC, Ramires JA, Kalil Filho R.

J Thorac Cardiovasc Surg. 2013 Nov;146(5):1105-12. doi: 10.1016/j.jtcvs.2012.08.015. Epub 2012 Aug 31.

PMID:
22944095
[PubMed - indexed for MEDLINE]
9.

Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial.

Hueb W, Gersh BJ, Rezende PC, Garzillo CL, Lima EG, Vieira RD, Garcia RM, Favarato D, Segre CA, Pereira AC, Soares PR, Ribeiro E, Lemos P, Perin MA, Strunz CC, Dallan LA, Jatene FB, Stolf NA, Hueb AC, Dias R, Gaiotto FA, da Costa LM, Oikawa FT, de Melo RM, Serrano CV Jr, de Ávila LF, Villa AV, Filho JR, Nomura C, Ramires JA, Filho RK; MASS-V Study Group.

BMC Cardiovasc Disord. 2012 Aug 16;12:65. doi: 10.1186/1471-2261-12-65.

PMID:
22898311
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Cancer-related deaths among different treatment options in chronic coronary artery disease: results of a 6-year follow-up of the MASS II study.

Vieira RD, Pereira AC, Lima EG, Garzillo CL, Rezende PC, Favarato D, Hueb AC, Gersh BJ, Ramires JA, Hueb W.

Coron Artery Dis. 2012 Mar;23(2):79-84. doi: 10.1097/MCA.0b013e32834f112a.

PMID:
22157410
[PubMed - indexed for MEDLINE]
11.

Hypotheses, rationale, design, and methods for prognostic evaluation in type 2 diabetic patients with angiographically normal coronary arteries. The MASS IV-DM Trial.

Hueb W, Lopes N, Soares PR, Gersh BJ, Lima EG, Vieira RD, Garzillo CL, Garcia RR, Pereira AC, Strunz CM, Meneguetti C, Tsutsui J, Parga J, Lemos P, Hueb A, Ushida A, Maranhão R, Chamone DA, Ramires JA.

BMC Cardiovasc Disord. 2010 Sep 29;10:47. doi: 10.1186/1471-2261-10-47.

PMID:
20920271
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Five-year follow-up of a randomized comparison between off-pump and on-pump stable multivessel coronary artery bypass grafting. The MASS III Trial.

Hueb W, Lopes NH, Pereira AC, Hueb AC, Soares PR, Favarato D, Vieira RD, Lima EG, Garzillo CL, Paulitch Fda S, César LA, Gersh BJ, Ramires JA.

Circulation. 2010 Sep 14;122(11 Suppl):S48-52. doi: 10.1161/CIRCULATIONAHA.109.924258.

PMID:
20837925
[PubMed - indexed for MEDLINE]
Free Article
13.

Mild chronic kidney dysfunction and treatment strategies for stable coronary artery disease.

Lopes NH, da Silva Paulitsch F, Pereira A, Garzillo CL, Ferreira JF, Stolf N, Hueb W.

J Thorac Cardiovasc Surg. 2009 Jun;137(6):1443-9. doi: 10.1016/j.jtcvs.2008.11.028. Epub 2009 Feb 5.

PMID:
19464462
[PubMed - indexed for MEDLINE]
14.

Comparative costs between myocardial revascularization with or without extracorporeal circulation.

Girardi PB, Hueb W, Nogueira CR, Takiuti ME, Nakano T, Garzillo CL, Paulitsch Fda S, Góis AF, Lopes NH, Stolf NA.

Arq Bras Cardiol. 2008 Dec;91(6):340-6.

PMID:
19142359
[PubMed - indexed for MEDLINE]
Free Article
15.

Impact of metabolic syndrome on the outcome of patients with stable coronary artery disease: 2-year follow-up of the MASS II study.

Lopes NH, Paulitsch FS, Pereira AC, Góis AF, Gagliardi A, Garzillo CL, Ferreira JF, Stolf NA, Hueb W.

Coron Artery Dis. 2008 Sep;19(6):383-8. doi: 10.1097/MCA.0b013e328306aa8a.

PMID:
18955830
[PubMed - indexed for MEDLINE]
16.

Characterization of reactive astrocytes in the chronic phase of the pilocarpine model of epilepsy.

Garzillo CL, Mello LE.

Epilepsia. 2002;43 Suppl 5:107-9.

PMID:
12121303
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk